NCT02949752View on ClinicalTrials.gov

Aripiprazole as an Adjunct to Atypical Antipsychotics for Weight Reduction and Improvement in Metabolic Profile

PHASE4CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

October 1, 2019

Study Completion Date

January 1, 2020

Conditions
Antipsychotics Weight Gain
Interventions
DRUG

Aripiprazole

Aripiprazole 5 mg every morning will be prescribed for 12 weeks

Trial Locations (1)

556121

Institute of Mental Health, Singapore

All Listed Sponsors
lead

Institute of Mental Health, Singapore

OTHER

NCT02949752 - Aripiprazole as an Adjunct to Atypical Antipsychotics for Weight Reduction and Improvement in Metabolic Profile | Biotech Hunter | Biotech Hunter